Clinical Trial Update: Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating veliparib in combination with radiation therapy and temozolomide for newly diagnosed malignant glioma; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Temozolomide (Temodar) (Temozolomide)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anaplastic Astrocytoma, Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-04-23